AFAO Health Promotion Officer, Ben Wilcock, reports back on the 2nd International HIV/Viral Hepatitis Co-infection Meeting, held in Vancouver.
On Friday and Saturday (17-18 July), I was fortunate to be able to
attend the 2nd International HIV/Viral Hepatitis Co-infection Meeting in
Vancouver. It was an official event before the IAS Conference on HIV
Pathogenesis, Treatment and Prevention (
#IAS2015).
There
were a range of issues covered relating to HIV and viral hepatitis
co-infections (both hepatitis B and C), with a particular focus on
building momentum towards expanding hepatitis C treatment access
globally for people co-infected with HIV and viral hepatitis, in the
light of the new range of direct-acting antiviral (DAA) treatments for
hepatitis C now available (though often not yet accessible) and in the
pipeline. (See:
#ACureForAll for more info).